Reductive trapping of substrate to methylamine oxidase from Arthrobacter P1  by Hartmann, Christa & Klinman, Judith P.
Volume 261, number 2, 441444 FEBS 08190 February 1990 
Reductive trapping of substrate to methylamine oxidase from 
Arthrobacter I?1 
Christa Hartmann* and Judith P. Unman 
Department of Chemistry, University of California, Berkeley, CA 94720, USA 
Received 6 December 1989; revised version received 19 haury 1990 
Methylamine oxidase (EC 1.4.3.6) from ~r~~~o~~crer Pl was inactivated by NaCNBH, in the presence of p4C]benzylamine, l ading to the incorp- 
oration of I mol of radiolabeled substrate/m01 of enxyrne subunit at complete inactivation. By contrast, no labeling of enzyme was observed using 
PHJNaCNBH, as reductant. These results are analogous to those previously reported for the eukaryotic enzyme, bovine serum plasma amine oxid- 
ase [(1987) J. Biol. Chem. 262, 962-9651. The observed pattern of labeling is consistent with the presence of dicarbonyl cofactor at the active site 
of methylamine oxidase. Further, these studies suggest hat our reductive trapping technique, in which the pattern of radiolabeling of an enzyme 
is compared using C-14 substrate vs tritiated reductant, may serve as a general assay for covalently bound dicarbonyl structures. 
Methylamine oxidase; P~ol~uino~ne quinone; Copper-containing amine oxidase 
1. INTRODUCTION 
In an earlier study, bovine serum amine oxidase was 
shown to be reductively inactivated in the presence of 
sodium cyanoborohydride and amine substrate [ 11. 
This result was taken as evidence for a covalent adduct 
between substrate and cofactor via Schiff base forma- 
tion, suggesting an aminotransferase mechanism for 
substrate oxidation. In contrast to pyridoxal phosphate 
chemistry, however, no tritium was observed to be 
transferred from 13H]NaCNBH3 into inactivated en- 
zyme. This ability to trap ‘?-substrate, without a con- 
comitant transfer of label from reductant, has been 
attributed to the presence of an active site dicarbonyl 
cofactor [1,2]. As reported originally by Lobenstein- 
Verbeek et al. [3] and Ameyama et al. [4], evidence ex- 
ists for the a-dicarbonyl-containing species, pyrrolo- 
quinoline quinone (PQQ), at the active sites of 
numerous eukaryotic amine oxidases [5,6]. 
In the present study, methylamine oxidase (EC 
1.4.3.6) from Arthrobacter Pl was chosen to examine 
the suitability of our double labeling methodology to a 
bacterial amine oxidase believed to contain covalently 
bound PQQ [7]. As described herein, methylamine ox- 
idase can only be inactivated by NaCNBH3 in the 
presence of substrate, leading to the incorporation of 
1 mol of [r4C]benzylamine/mol of enzyme subunit at 
Correspondence address: J.P. Ktinman, Department of Chemistry, 
University of California. Berkeley, CA 94720, USA 
* Present address: Department of Pharmaceutical Chemistry, 
University of California, San Francisco, CA 94143, USA 
complete inactivation. Analogous to previous results 
obtained with bovine serum amine oxidase, no tritium 
was incorporated into protein upon reduction with 
[3H]NaCNBH3. These results suggest that our reductive 
trapping technique, in which the pattern of radiolabel- 
ing of an enzyme is compared using C-14 substrate vs 
tritiated reductant, may serve as a general assay for 
protein-bound dicarbonyl cofactors. 
2. MATERIALS AND METHODS 
2.1. Materiais 
Alf materials were of reagent grade unless otherwise indicated. 
~L-14C]ben~l~n~HCl (sp. act. 12-16 mCi/mmol), liver alcohol 
dehydrogenase (2 U/mg) and G-25 Sephadex (medium grade) were 
purchased from Sigma and [3H]NaCNBHs was from Amersham (sp. 
act. 5.40 Ci/mmol). Bovine serum albumin and NaCNBHs were ob- 
tained from Aldrich and NADH was from P-L Biochemicals. 
2.2. General methods 
Radioa~iv~ty was determined on a Beckman LS-8000 Liquid Scin- 
tillation spectrometer using a cocktail comprises of Chemfluor with 
surfactor X-100 (E&K Scientific Products) in toluene (30: 70 v/v). 
Methylamine oxidase from Arthrobacter Pl was a kind gift from 
W.S. M&tire (Veterans Administration Hospital, San Francisco, 
CA). This enzyme, which is a dimer of 82 kDa subunits, indicated 
r95% purity by gel electrophoresis (W.S. Macintire, personal com- 
munication). Activity was assayed s~~rophotome~i~lly on a Gary 
118 spectrophotometer using 10 mM benxylamine as substrate in 
100 mM phosphate buffer, pH 7.2; the increase in absorbance at 
250 nm due to benxaldehyde formation was monitored, de = 
12800 M-’ .cm-’ [8]. Protein concentration was determined spec- 
trophotometrically at 280 nm, Elem - ‘% 18.2 for methylamine oxidase 
I71. 
2.3. Phe~y~hydraztne itrations with methylamine oxidase 
Phenylhydraxine solutions were made immediately prior to use and 
were protected from light throughout he course of the experiments. 
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A typical titration included 1 ml of enzyme (l-2.5 mg/ml) to which 
was added l-2 ,LLI aliquots of 1.7 mM phenylhydrazine. Reaction was 
allowed to proceed for 5-10 min between additions. The course of 
the titration was monitored by measuring the absorbance at 440 nm 
for methylamine oxidase. An approximate xtinction coefficient for 
the phenylhydrazone of methylamine oxidase was determined by tak- 
ing the final absorbance of the complex and dividing by the nmol of 
phenylhydrazine which had reacted. 
2.4. Inactivation of enzyme with [3HJNaCNBHJ 
Reaction conditions were identical to those previously described 
[I], with the exception that 20 mM [3H]NaCNBHr (1.1 x 
10’ cpm/pmol or 5.5 x 10’ cpm/pmol) was used as reductant. Isola- 
tion and counting of the protein peaks and confirmation of the 
specific activity of the [3H]NaCNBH3 followed the earlier protocols 
of Hartmann and Klinman [ 11. 
3. RESULTS AND DISCUSSION 
3.1. Phenylhydrazine titration of methylamine oxidase 
Prior to attempting reductive trapping of substrate to 
enzyme, it was important to determine the concentra- 
tion of active sites. Phenylhydrazine is a potent irrever- 
sible inhibitor of methylamine oxidase. The titration of 
methylamine oxidase was monitored by the increase in 
absorbance at 440 nm (fig.lA). The complex formed 
between enzyme and phenylhydrazine has an approx- 
imate extinction coefficient of 30 mM_’ - cm-‘. From 
the dependence of absorbance at 440 nm on the ratio of 
phenylhydrazine to methylamine oxidase, fig. lB, 
-0.80 mol of phenylhydrazine were concluded to react 
with 1.0 mol of methylamine oxidase of specific activi- 
ty 0.85 U/mg. It should be noted that a true tangent 
was not observed in fig. lB, such that the actual ratio of 
phenylhydrazine to enzyme may in fact be greater than 
0.80: 1.0. This result differs from previous titrations 
with methylhydrazine, which led to the conclusion of 
only one active site per dimer [7]. Recent anaerobic 
titrations of methylamine oxidase indicate two moles of 
product formed per enzyme dimer (Dooley et al., per- 
sonal communication). 
3.2. 14C versus 3H trapping of substrate with 
methylamine oxidase 
Methylamine oxidase was reacted with [14C]ben- 
zylamine and NaCNBHs, giving the time courses for in- 
activation and radiolabeling in fig.2A. These data are 
replotted in fig.2B, illustrating the correspondence bet- 
ween enzyme inactivation and radiolabeling and the ex- 
trapolation to one mol of 14C-benzylamine per mol of 
enzyme subunit at 100% inactivation. Incubation of 
enzyme with radiolabeled substrate in the absence of 
reductant led to retention of enzyme activity and no in- 
corporation of radioactivity into the protein. 
As with bovine serum amine oxidase, efforts were 
made to incorporate tritium into reductively trapped 
enzyme. Incubation of methylamine oxidase with high 
specific activity t3H]NaCNBH3 (1.1 x lo9 cpm/,umol) 
alone gave rise to -7% tritium incorporation which ap- 
peared to be time-independent. Incubation of enzyme 
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Fig.1. (A) Spectral changes induced by the addition of 
phenylhydrazine to methylamine oxidase. Methylamine oxidase 
(1.71 mg/ml) in 1 ml 0.10 M phosphate buffer, pH 7.2, was titrated 
with 1 ~1 aliquots of 1.7 mM phenylhydrazine, also in 0.10 M 
phosphate buffer, pH 7.2. (B) Stoichiometry of the reaction between 
methylamine oxidase (1.7 mg/ml) and 1.7 mM phenylhydrazine in 
phosphate buffer, pH 7.2, monitored at 440 nm. 
in the presence of benzylamine, [3H]NaCNBH3, 
NADH and liver alcohol dehydrogenase to 89% inac- 
tivation yielded 16.8% incorporation of tritium. Since 
the amount of tritium incorporated + substrate was 
identical, the percent incorporation in the presence of 
substrate is attributed to background for this enzyme. 
It should be emphasized that the experiments in fig.2 
were carried out in the presence of excess horse liver 
alcohol dehydrogenase (and NADH) to convert pro- 
duct aldehyde to alcohol. Reactions run in the absence 
of alcohol dehydrogenase indicated 100% incorpora- 
tion of radiolabel at only 45% inactivation. This result, 
which suggests a non-specific condensation of product 
benzaldehyde with protein (lysyl) side chains [lo], em- 
, * 
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Fig.2. (A) Time course for inactivation and labeling of methylamine 
oxidase. Enzyme at a concentration of 2-3 mg/ml was incubated 
with [14C]~~l~ine and NaCNBHs in 50 mM/Pi, pH 6.04, at 
4°C. Activities (O-XI) and 14C content (t--*) were determined 
following gel filtration; enzyme activity was corrected for some loss 
following incubation of enzyme with NaCNBHs alone (lOal, at 
120 mitt). Substrate concentration was maintained at approximately 
20 mM throughout the course of enzyme inactivation; initial 
reductant concentration was 20 mM. (B) A replot of the data in (A) 
showing the correspondence between enzyme inactivation and 
radiolabeling and the extrapolation to one mol of [‘4C]benzylamine 
per mol of enzyme subunit at 100% inactivation. 
phasizes the importance of the use of a coupled assay 
system in experiments aimed at correlating enzyme in- 
activation with the incorporation of radiolabeled 
substrate. 
A mechanistic explanation which will account for 
our results is shown in scheme 1. According to this 
scheme, covalent adduct formation between substrate 
and cofactor (1) precedes reduction by NaCNBH3. 
Although tritiated reductant is predicted to initially 
label the enzyme (Z), subsequent (possibly base cata- 
lyzed) enolization to generate the more stable form of 
the cofactor (3) leads to loss of tritium. As originally 
proposed by Suva and Abeles [ 111, there is increasing 
evidence for base catalysis in the bovine serum amine 
oxidase catalyzed conversion of the substrate-amine to 
product imine [12,13]. 
Scheme 1, Mechanism explaining the experimental observations of 
C-14 inco~oration without tritium incorporation. The r4C-Iabeled 
substrate (*) forms a Schiff base with cofactor, 1, which undergoes 
reduction by r3H]NaCNBH3. Although the enzyme will initially 
incorporate tritium, 2, subsequent enolization will generate the more 
stable form of the cofactor, 3 (adapted from [l]). 
In the earlier study of bovine serum amine oxidase 
[1], no tritium was found to be incorporated into 
recovered benzylamine, contrary to results reported by 
Suva and Abeles [l l] . The latter authors demonstrated 
the presence of [ 1(S)-3H]benzylamine following 
[3H]NaBH4 reduction of plasma amine oxidase at pH 
8.0, but used a different substrate, pH and reductant 
from Hartmann and Klinman [ 11. With benzylamine as 
substrate for bovine serum amine oxidase, pre-steady- 
state and steady-state isotope effects indicate that the 
major enzyme form is the enzyme substrate complex 
[14], such that t3H]NaCNBH3 reduction could lead to 
tritiated cofactor but would not be expected to label 
substrate. For methylamine oxidase no effort was made 
to determine whether tritium had been incorporated in- 
to substrate. As discussed previously [l], the stable in- 
corporation of C-14 into enzyme implies that the 
secondary amine (3) either oxidizes more slowly than 
the primary amine generated under catalytic conditions 
or is resistant o oxidation. 
3.3. Retention of rudiolabel fob wing dialysis 
In our previous study of bovine serum amine ox- 
idase, the retention of counts in radiolabeled enzyme 
was found to be dependent on the method of treatment. 
Whereas incubation of labeled enzyme for 2.5 h 
followed by rechromatography led to full retention of 
counts, extensive dialysis or denaturation led to the 
release of -50% of the radiolabel from the protein. 
Although this result was originally att~but~ to half 
of the sites reactivity [l], it has now been shown that 
earlier preparations of bovine serum amine oxidase 
were only half active [15]. To assay for retention of 
label for methylamine oxidase, enzyme was dialyzed 
with the use of a Centricon apparatus which permits 
close to full recovery of radioactivity in the supernatant 
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Table 1 
Effect of dialysis on the retention of radiolabel in reductively trapped 
methyl~ine oxidase 
Time of inactiva- Supernatant Protein % cpm in 
tion (min) (cpm) (cpm) protein 
20 886 2842 76 
60 1177 4384 79 
90 1037 3877 79 
120 1496 6437 81 
and protein. As summarized in table 1, such treatment 
led to the loss of -20% of radiolabel. Since 
phenylhydr~ine titration with methyl~ine oxidase ex- 
hibited a similar end point (of 0.8 mol of reactive 
phenylhydrazine sites per mol of enzyme active sites), 
we suggest hat methylamine oxidase of specific activity 
0.850 U/mg corresponds to enzyme which is -80% 
active. 
3 4. rrn~l~c~~~o~s for sfructure of the organic cofactor 
in copper amine oxidases 
In 1984, Lobenstein-Verbeek et al. [3], and 
Ameyama et al. [4] independently reported results 
which implicated PQQ as the organic cofactor in 
bovine serum amine oxidase. Spectral data in support 
of the presence of PQQ in both serum amine oxidases 
and lysyl oxidase were subsequently published [ 16- 181. 
It should be emphasized, however, that an unam- 
biguous structural proof of PQQ as the covalently 
bound cofactor in the copper amine oxidases has not 
yet been advanced. The latter point is particularly im- 
portant in light of the recent X-ray studies of Ho1 et al. 
[ 191 on methylamine dehydrogenase. Despite the prior 
evidence for PQQ in this protein [20], X-ray diffraction 
patterns indicate an active site dicarbonyl which lacks 
the pyridine ring present in authentic PQQ [19]. 
In concluding, we note that while the reductive trap- 
ping data presented herein and in Hartmann and Klin- 
man [l] cannot distinguish covalently bound PQQ 
from alternative structures, they do provide strong 
chemical evidence for a dicarbonyl-containing cofactor 
in the pro- and eukaryotic copper amine oxidases. 
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